NovaBridge Biosciences
NBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $68 | $2,141 | $3,214 | $3,524 |
| Short-Term Investments | $105 | $20 | $235 | $753 |
| Receivables | $1 | $2 | $5 | $61 |
| Inventory | $0 | $29 | -$80 | $4 |
| Other Curr. Assets | $2 | $16 | $253 | $4,046 |
| Total Curr. Assets | $177 | $2,337 | $3,626 | $4,782 |
| Property Plant & Equip (Net) | $4 | $6 | $124 | $158 |
| Goodwill | $0 | $0 | $163 | $163 |
| Intangibles | $0 | $17 | $119 | $120 |
| Long-Term Investments | $31 | $2 | $31 | $380 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $252 | $11 | $27 |
| Total NC Assets | $36 | $276 | $447 | $848 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $213 | $2,613 | $4,074 | $5,629 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $1 | $52 | $6 | $31 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $2 | $2 | $2 |
| Other Curr. Liab. | $8 | $358 | $651 | $591 |
| Total Curr. Liab. | $8 | $412 | $660 | $624 |
| LT Debt | $3 | $82 | $32 | $194 |
| Deferred Rev, NC | $0 | $0 | $0 | $224 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $401 | $374 | -$1 |
| Total NC Liab. | $3 | $483 | $406 | $418 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $45 | $36 | $112 |
| Total Liabilities | $12 | $895 | $1,065 | $1,042 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $2 | $0 | $28 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,286 | -$8,328 | -$6,767 | -$4,355 |
| AOCI | $33 | $40 | $217 | -$187 |
| Other Equity | $1,454 | $10,006 | $9,558 | $9,101 |
| Total Equity | $201 | $1,718 | $3,008 | $4,588 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $213 | $2,613 | $4,074 | $5,629 |
| Net Debt | -$64 | -$2,008 | -$3,176 | -$3,299 |